News archive

Denna sida på svenska
Datum Nyheter Taggar
06 Dec 2017 Clinical utility of gene signatures in breast cancer patients Breast cancer, Cancer genetics
24 Oct 2017 Study of protein expression in mouse ovarian follicles Cancer and Oncology, Obstetrics, Proteomics
28 Mar 2017 Two junior researchers at OnkPat receives funding for their positions from the Swedish Cancer Society Cancer and Oncology, Funding
23 Mar 2017 OnkPat professor earns prestigious grant from ERC Cancer and Oncology, Grant
10 Mar 2017 Review in Seminars in Cancer Biology Cancer and Oncology, Publication
10 Mar 2017 New potential target for breast cancer treatment Breast cancer, Publication
13 Jan 2017 Jonas Bergh earns Visiting Professorship at Oxford University Cancer and Oncology, International, Nobel prize, Professor
09 Jan 2017 OnkPat researcher receives funding from SSMF Cancer and Oncology, Funding
22 Nov 2016 Millions to OnkPat researchers from the Erling-Persson Family Foundation Award, Cancer and Oncology, Grant
14 Nov 2016 Tailored, Dense-Dose Chemotherapy for Early Breast Cancer Does Not Result in Significant Improvement in Recurrence-Free Survival Breast cancer, Cancer and Oncology
13 Sep 2016 Study explains mechanisms behind glioblastoma influence on the immune system Cancer and Oncology, Immunology
17 Jun 2016 Onkpat professors leading strategic cancer work Cancer and Oncology
17 Jun 2016 Inherited mutation doubles the risk of death from malignant melanoma Cancer and Oncology, Malignant Melanoma, Skin cancer
08 Jun 2016 Newly discovered mechanism may restrict breast cancer growth Breast cancer, Cancer and Oncology
04 May 2016 KI researchers win environmental medicine award Cancer and Oncology, Environmental Medicine, Prize
04 Apr 2016 PCM National Conference April 6 Cancer and Oncology, Pathology
30 Mar 2016 KI professor awarded prestigeous grant Award, Cancer and Oncology, Grant, Pathology
30 Mar 2016 Cancer foundation awards KI staff

Clinical utility of gene signatures in breast cancer patients

06 Dec 2017

Nick Tobin, Arian Lundberg and colleagues have shown the broad clinical utility of the Recurrence Score and PAM50 breast cancer gene signatures in two papers published simultaneously in Clinical Cancer Research. In paper 1, a collaboration with Dr. Thomas Hatschek and Prof. Jonas Bergh, Tobin et al...
Breast cancerCancer genetics

Study of protein expression in mouse ovarian follicles

24 Oct 2017

In a recent publication in Molecular Human Reproduction, researchers at OnkPat could identify the specific proteome profiling of mouse ovarian follicles at three different developmental stages. To do that, the researchers isolated the follicles and cultured them in vitro . This is the first protein...
Cancer and OncologyObstetricsProteomics

Two junior researchers at OnkPat receives funding for their positions from the Swedish Cancer Society

28 Mar 2017

Christofer Juhlin receives funding for six years at part time 50% via the Junior Clinical Investigator Award from the Swedish Cancer Society. The project is entitled ”Utilization of whole-genome sequencing to improve diagnosis, prognostication and treatment of thyroid cancer”. In addition,...
Cancer and OncologyFunding

OnkPat professor earns prestigious grant from ERC

23 Mar 2017

Klas Wiman , professor at the department of Oncology-Pathology has been awarded a grant from the European Research Council (ERC) for the project "Restoration of tumor suppressor function by induction of translational read-through of premature termination codons - a strategy for improved cancer...
Cancer and OncologyGrant

Review in Seminars in Cancer Biology

10 Mar 2017

Researchers at OnkPat together with Italian researchers review recent studies on the acidic tumor environment and how this affects tumor growth and therapeutic efficacy. The tumor environment is characterized by a low pH. Besides contributing to tumor pathogenesis, the low pH can also negatively...
Cancer and OncologyPublication

New potential target for breast cancer treatment

10 Mar 2017

Researchers at OnkPat have found that breast cancer stem cells are dependent on a certain estrogen receptor to survive. The findings, which are presented in Journal of the National Cancer Institute opens up for new treatment strategies for breast cancer. Most forms of breast cancer are dependent on...
Breast cancerPublication

Jonas Bergh earns Visiting Professorship at Oxford University

13 Jan 2017

Professor Jonas Bergh at the Department of Oncology-Pathology has from 1 January 2017 been conferred the title of Visiting Professor of Breast Cancer Research at Oxford University. The visiting professorship will last until 31 December 2019. Jonas has also been appointed member of the Nobel...
Cancer and OncologyInternationalNobel prizeProfessor

OnkPat researcher receives funding from SSMF

09 Jan 2017

Christofer Juhlin is one of eight young researchers who receives funding from Swedish Society for Medical Research (SSMF). The eight researchers share 24 million SEK for the first two years of research, with the possibility of two additional years, i.e a total of 48 million SEK.
Cancer and OncologyFunding

Millions to OnkPat researchers from the Erling-Persson Family Foundation

22 Nov 2016

The Erling-Persson Family Foundation has awarded a large grant to a KTH project where OnkPat's Rolf Lewensohn and Kristina Viktorsson have key roles. Project: Detection and analysis of tumour- and blood-borne markers using new nanotechnology for the early diagnosis and monitoring of cancer Project...
AwardCancer and OncologyGrant

Tailored, Dense-Dose Chemotherapy for Early Breast Cancer Does Not Result in Significant Improvement in Recurrence-Free Survival

14 Nov 2016

Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free survival, and nonhematologic toxic effects were more frequent in the...
Breast cancerCancer and Oncology

Study explains mechanisms behind glioblastoma influence on the immune system

13 Sep 2016

Glioblastomas exert an influence on the microglia, immune cells of the brain, which causes them to stimulate cancer growth rather than attacking it. In a study published in the journal Nature Immunology , an international research team led from Karolinska Institutet now explains the molecular...
Cancer and OncologyImmunology

Onkpat professors leading strategic cancer work

17 Jun 2016

A new Executive Board for StratCan, with wide representation from Onkpat, has been approved by the KI Board of Research. Jonas Bergh will lead the board as director alongside co-director Arne Östman . Additionally, Lars Holmgren , Andreas Lundqvist and Olli Kallioniemi have been elected as board...
Cancer and Oncology

Inherited mutation doubles the risk of death from malignant melanoma

17 Jun 2016

People with malignant melanoma with an inherited mutation in a certain gene are twice as likely to die of the disease, according to a new study carried out by researchers at Karolinska Institutet and Lund University in Sweden. The finding, which is published in The Journal of the National Cancer...
Cancer and OncologyMalignant MelanomaSkin cancer

Newly discovered mechanism may restrict breast cancer growth

08 Jun 2016

Charlotte Rolny and colleagues at the Department of Oncology-Pathology have discovered a new mechanism that could be the key to a new strategy to restrict breast cancer growth. This mechanism means that the anti-tumor macrophages can be selectively expanded in the tumor while growth of tumorigenic...
Breast cancerCancer and Oncology

KI researchers win environmental medicine award

04 May 2016

The 2016 Environmental Medicine Prize, founded by the Swedish Cancer and Allergy Foundation, is granted to KI co-workers professor Jan-Inge Henter and researcher Maria Shoshan , from the Department of Oncology-Pathology. The Cancer and Allergy Foundation clarifies its decision: Researcher Maria...
Cancer and OncologyEnvironmental MedicinePrize

PCM National Conference April 6

04 Apr 2016

Welcome to the PCM National Conference on Wednesday April 6, open for everyone to attend. The purpose of the conference is to explore possibilities for coordination and cooperation to establish precision/personalized cancer medicine (PCM). The event is sponsored by the Swedish Foundation for...
Cancer and OncologyPathology

KI professor awarded prestigeous grant

30 Mar 2016

Klas Wiman , professor at the Department of Oncology-Pathology, receives the grant for the project ”Restoration of tumor suppressor function by induction of translational read-through of premature termination codons – a strategy for improved cancer therapy”. The ERC Advanced Grants are designed for...
AwardCancer and OncologyGrantPathology

Cancer foundation awards KI staff

30 Mar 2016

Following the decision at the Research Board meeting March 8, 2016, two additional posts were awarded by Cancerfonden to the Department of Oncology-Pathology: Mercedes Herrera , postdoctor, and Johan Hartman , junior clinical investigator. This year's notice by Cancerfonden can be summarized as a...